DJIA 17,387.21 -291.49 -1.65%
NASDAQ 4,681.50 -90.27 -1.89%
S&P 500 2,029.55 -27.54 -1.34%
market minute promo

Seattle Genetics (NASDAQ: SGEN)

33.20 0.18 (0.55%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

SGEN $33.20 0.55%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $32.67
Previous Close $33.02
Daily Range $32.57 - $33.66
52-Week Range $30.05 - $55.99
Market Cap $4.1B
P/E Ratio -63.50
Dividend (Yield) $0.00 (0.0%)
Volume 987,971
Average Daily Volume 1,414,472
Current FY EPS -$0.66

Sector

Healthcare

Industry

Drugs

Seattle Genetics (SGEN) Description

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Website: http://www.seattlegenetics.com/

News & Commentary

Why Seattle Genetics, Inc. Stock Dove 12% in December

Seattle Genetics' shares get hammered following impressive clinical data from its rivals at the American Society of Hematology's annual meeting. Find out whether this dip represents a buying opportunity or a red flag.

Earnings Peek: Market Seems Determined To Keep Seattle Genetics In The $30s

First Week of SGEN September 18th Options Trading

Commit To Buy Seattle Genetics At $25, Earn 8.5% Annualized Using Options

ALPS Puts Twist On Biotech Investing With Medical Breakthrough ETF

Eli Lilly Inks Oncology Deals with Merck, Bristol-Myers - Analyst Blog

Seattle Genetics, Bristol-Myers to Study Adcetris-Opdivo - Analyst Blog

New Biotech ETF From ALPS

Bull of the Day: Incyte (INCY) - Bull of the Day

Seattle Genetics And Agios Pharmaceuticals: Opportunity Or Danger?

See More SGEN News...

SGEN's Top Competitors

SGEN $33.20 (0.55%)
Current stock: SGEN
BIIB $358.23 (-1.16%)
Current stock: BIIB
AMGN $158.42 (-0.82%)
Current stock: AMGN
CELG $122.36 (-1.42%)
Current stock: CELG